These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2164580)

  • 41. Gyrase inhibitors and intracellular DNA supercoiling.
    Franco RJ; Drlica K
    Biochem Soc Trans; 1986 Apr; 14(2):499-501. PubMed ID: 3011555
    [No Abstract]   [Full Text] [Related]  

  • 42. DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein.
    Gellert M; Fisher LM; O'Dea MH
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6289-93. PubMed ID: 230505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory activities of (-)-epigallocatechin-3-O-gallate against topoisomerases I and II.
    Suzuki K; Yahara S; Hashimoto F; Uyeda M
    Biol Pharm Bull; 2001 Sep; 24(9):1088-90. PubMed ID: 11558576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA Topoisomerases as Targets for Antibacterial Agents.
    Hiasa H
    Methods Mol Biol; 2018; 1703():47-62. PubMed ID: 29177732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Both DNA gyrase and reverse gyrase are present in the hyperthermophilic bacterium Thermotoga maritima.
    Guipaud O; Marguet E; Noll KM; de la Tour CB; Forterre P
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10606-11. PubMed ID: 9380682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reverse gyrase of Sulfolobus: purification to homogeneity and characterization.
    Nadal M; Jaxel C; Portemer C; Forterre P; Mirambeau G; Duguet M
    Biochemistry; 1988 Dec; 27(26):9102-8. PubMed ID: 2853975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.
    Tan CM; Gill CJ; Wu J; Toussaint N; Yin J; Tsuchiya T; Garlisi CG; Kaelin D; Meinke PT; Miesel L; Olsen DB; Lagrutta A; Fukuda H; Kishii R; Takei M; Oohata K; Takeuchi T; Shibue T; Takano H; Nishimura A; Fukuda Y; Singh SB
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4830-9. PubMed ID: 27246784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA supercoiling in Escherichia coli is under tight and subtle homeostatic control, involving gene-expression and metabolic regulation of both topoisomerase I and DNA gyrase.
    Snoep JL; van der Weijden CC; Andersen HW; Westerhoff HV; Jensen PR
    Eur J Biochem; 2002 Mar; 269(6):1662-9. PubMed ID: 11895436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines.
    Werner MM; Patel BA; Talele TT; Ashby CR; Li Z; Zauhar RJ
    Bioorg Med Chem; 2015 Sep; 23(18):6125-37. PubMed ID: 26320664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.
    Sandhaus S; Annamalai T; Welmaker G; Houghten RA; Paz C; Garcia PK; Andres A; Narula G; Rodrigues Felix C; Geden S; Netherton M; Gupta R; Rohde KH; Giulianotti MA; Tse-Dinh YC
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4028-36. PubMed ID: 27114277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of DNA topoisomerase activity in two strains of Mycoplasma fermentans and in Mycoplasma pirum.
    Horowitz S; Maor R; Priel E
    J Bacteriol; 1997 Nov; 179(21):6626-32. PubMed ID: 9352909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine 5'-O-(3-thio)triphosphate (ATPgammaS) promotes positive supercoiling of DNA by T. maritima reverse gyrase.
    Jungblut SP; Klostermeier D
    J Mol Biol; 2007 Aug; 371(1):197-209. PubMed ID: 17560602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I.
    Duan F; Li X; Cai S; Xin G; Wang Y; Du D; He S; Huang B; Guo X; Zhao H; Zhang R; Ma L; Liu Y; Du Q; Wei Z; Xing Z; Liang Y; Wu X; Fan C; Ji C; Zeng D; Chen Q; He Y; Liu X; Huang W
    J Med Chem; 2014 May; 57(9):3707-14. PubMed ID: 24588790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes.
    Pruss GJ; Manes SH; Drlica K
    Cell; 1982 Nov; 31(1):35-42. PubMed ID: 6297751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
    Wu P; Lawrence LE; Denbleyker KL; Barrett JF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clerocidin, a terpenoid antibiotic, inhibits bacterial DNA gyrase.
    McCullough JE; Muller MT; Howells AJ; Maxwell A; O'Sullivan J; Summerill RS; Parker WL; Wells JS; Bonner DP; Fernandes PB
    J Antibiot (Tokyo); 1993 Mar; 46(3):526-30. PubMed ID: 8386713
    [No Abstract]   [Full Text] [Related]  

  • 57. Positive supercoiling catalysed in vitro by ATP-dependent topoisomerase from Desulfurococcus amylolyticus.
    Slesarev AI
    Eur J Biochem; 1988 Apr; 173(2):395-9. PubMed ID: 2834207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.
    Pruss GJ; Franco RJ; Chevalier SG; Manes SH; Drlica K
    J Bacteriol; 1986 Oct; 168(1):276-82. PubMed ID: 3019999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening.
    Ostrov DA; Hernández Prada JA; Corsino PE; Finton KA; Le N; Rowe TC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3688-98. PubMed ID: 17682095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Archaebacterial reverse gyrase cleavage-site specificity is similar to that of eubacterial DNA topoisomerases I.
    Kovalsky OI; Kozyavkin SA; Slesarev AI
    Nucleic Acids Res; 1990 May; 18(9):2801-5. PubMed ID: 2160070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.